Resumen: Gilead esboza las prioridades de I+D para 2009

Show Health and Fitness Publications

Wed, February 4, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System

[ Wed, Feb 04th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf

[ Wed, Feb 04th 2009 ] - Market Wire

MEDNAX, Inc. Acquires Neonatal Practice

[ Wed, Feb 04th 2009 ] - Market Wire

Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11

[ Wed, Feb 04th 2009 ] - Market Wire

Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures

Tue, February 3, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment

[ Tue, Feb 03rd 2009 ] - Market Wire

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development

[ Tue, Feb 03rd 2009 ] - Market Wire

Affymax to Present at BIO CEO and Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses

[ Tue, Feb 03rd 2009 ] - Market Wire

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM

[ Tue, Feb 03rd 2009 ] - Market Wire

Amarin to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Amedisys Acquires Two Home Health Agencies in Arizona

[ Tue, Feb 03rd 2009 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.

[ Tue, Feb 03rd 2009 ] - Market Wire

Inspire Announces Webcast of Presentation at BIO CEO Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement

[ Tue, Feb 03rd 2009 ] - Market Wire

Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19

Mon, February 2, 2009

[ Mon, Feb 02nd 2009 ] - Market Wire

LHC Group and Ochsner Health System Complete Home Health Joint Venture

[ Mon, Feb 02nd 2009 ] - Market Wire

Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in

[ Mon, Feb 02nd 2009 ] - Market Wire

Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study

[ Mon, Feb 02nd 2009 ] - Market Wire

Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call

[ Mon, Feb 02nd 2009 ] - Market Wire

Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia

[ Mon, Feb 02nd 2009 ] - Market Wire

ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma

[ Mon, Feb 02nd 2009 ] - Market Wire

Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital

[ Mon, Feb 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)

[ Mon, Feb 02nd 2009 ] - Market Wire

Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®

[ Mon, Feb 02nd 2009 ] - Market Wire

Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment

[ Mon, Feb 02nd 2009 ] - Market Wire

Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S

[ Mon, Feb 02nd 2009 ] - Market Wire

LifePoint Hospitals Acquires Rockdale Medical Center

[ Mon, Feb 02nd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

Sun, February 1, 2009

[ Sun, Feb 01st 2009 ] - Market Wire

FORTIS: Fortis holding announcement

Sat, January 31, 2009

[ Sat, Jan 31st 2009 ] - Market Wire

FORTIS: Fortis holding publishes addendum to shareholder circular

[ Sat, Jan 31st 2009 ] - Market Wire

Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d

Fri, January 30, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Teva Announces Approval of Generic Risperdal® Oral Solution

[ Fri, Jan 30th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer

[ Fri, Jan 30th 2009 ] - Market Wire

First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence

[ Fri, Jan 30th 2009 ] - Market Wire

DexCom Announces Pricing of Public Offering of Common Stock

[ Fri, Jan 30th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference

[ Fri, Jan 30th 2009 ] - Market Wire

GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry

[ Fri, Jan 30th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas

[ Fri, Jan 30th 2009 ] - Market Wire

Progen-Avexa Merger Update

[ Fri, Jan 30th 2009 ] - Market Wire

St. Jude Medical Announces 2009 Annual Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

SonoSite Introduces Powerful New Turbo Technology for S Series"

[ Fri, Jan 30th 2009 ] - Market Wire

GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame

[ Fri, Jan 30th 2009 ] - Market Wire

Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time

[ Fri, Jan 30th 2009 ] - Market Wire

REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us

[ Fri, Jan 30th 2009 ] - Market Wire

Santarus Submits New Drug Application for ZEGERID Tablet Product

Thu, January 29, 2009

[ Thu, Jan 29th 2009 ] - Market Wire

EXACT Sciences Regains NASDAQ Compliance

[ Thu, Jan 29th 2009 ] - Market Wire

CompCare Acquires Core Corporate Consulting Group, Inc.

[ Thu, Jan 29th 2009 ] - Market Wire

Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast

[ Thu, Jan 29th 2009 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $125,000 to North Carolina Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $857,500 to Non-Profits in Florida

[ Thu, Jan 29th 2009 ] - Market Wire

Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria

[ Thu, Jan 29th 2009 ] - Market Wire

Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete

[ Thu, Jan 29th 2009 ] - Market Wire

Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009

[ Thu, Jan 29th 2009 ] - Market Wire

Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program

[ Thu, Jan 29th 2009 ] - Market Wire

ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results

[ Thu, Jan 29th 2009 ] - Market Wire

University of Texas at Austin Acquires SOLiD System to Advance Genomic Research

[ Thu, Jan 29th 2009 ] - Market Wire

Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH

[ Thu, Jan 29th 2009 ] - Market Wire

Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs

[ Thu, Jan 29th 2009 ] - Market Wire

Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17

[ Thu, Jan 29th 2009 ] - Market Wire

POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint

[ Thu, Jan 29th 2009 ] - Market Wire

Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5

Wed, January 28, 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Enzon Nominates Two New Candidates for Its Board of Directors

[ Wed, Jan 28th 2009 ] - Market Wire

Aetna Announces 2009 Annual Meeting Details

[ Wed, Jan 28th 2009 ] - Market Wire

CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate

[ Wed, Jan 28th 2009 ] - Market Wire

Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner

[ Wed, Jan 28th 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call

[ Wed, Jan 28th 2009 ] - Market Wire

Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office

[ Wed, Jan 28th 2009 ] - Market Wire

Resumen: Gilead esboza las prioridades de I+D para 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt

[ Wed, Jan 28th 2009 ] - Market Wire

Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25

[ Wed, Jan 28th 2009 ] - Market Wire

VIVUS Announces Senior Management Promotions

[ Wed, Jan 28th 2009 ] - Market Wire

Geron Announces John Walker Resigns as Director

[ Wed, Jan 28th 2009 ] - Market Wire

Sequenom Terminates Exchange Offer to Acquire EXACT Sciences

[ Wed, Jan 28th 2009 ] - Market Wire

Medtronic Expands CURE-AF Clinical Program into Europe and Canada

[ Wed, Jan 28th 2009 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009

[ Wed, Jan 28th 2009 ] - Market Wire

U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating

[ Wed, Jan 28th 2009 ] - Market Wire

ZymoGenetics Secures Worldwide Rights to IL-21

Tue, January 27, 2009

[ Tue, Jan 27th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Inc. Prov .. ication on Engagement of Investor Relations Group

[ Tue, Jan 27th 2009 ] - Market Wire

UnitedHealth Group/PacifiCare Awards More Than $5 .. Grants to Help Improve Health Care in California

[ Tue, Jan 27th 2009 ] - Market Wire

Cavit Sciences, Inc.: Cavit Sciences Announces Update to Shareholders

[ Tue, Jan 27th 2009 ] - Market Wire

UnitedHealth Group?s Evercare Business Awarded for Innovation in Coordinated Care

[ Tue, Jan 27th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Inc. Engages Investor Relations Group

[ Tue, Jan 27th 2009 ] - Market Wire

Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash

[ Tue, Jan 27th 2009 ] - Market Wire

Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months

[ Tue, Jan 27th 2009 ] - Market Wire

DOR BioPharma, Inc.: DOR BioPharma Announces Appo .. pher J. Schaber, PhD, to BioNJ Board of Directors

[ Tue, Jan 27th 2009 ] - Market Wire

Alnylam Promotes Akshay Vaishnaw to Senior Vice President, Clinical Research

[ Tue, Jan 27th 2009 ] - Market Wire

St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results

[ Tue, Jan 27th 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific Adds Midwest Sales Representative

[ Tue, Jan 27th 2009 ] - Market Wire

Sequenom Commences Exchange Offer to Acquire EXACT Sciences

[ Tue, Jan 27th 2009 ] - Market Wire

PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split

[ Tue, Jan 27th 2009 ] - Market Wire

Inspire Initiates Phase 3 Prolacria" Dry Eye Trial under Special Protocol Assessment Agreement

[ Tue, Jan 27th 2009 ] - Market Wire

Illumina Launches Suite of Next-Generation Sequencing Kits

[ Tue, Jan 27th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Onyx Pha .. wfield Exploration, D.R. Horton, KB Home and MGIC

[ Tue, Jan 27th 2009 ] - Market Wire

SCOR: SCOR sets up Zurich Hub

Mon, January 26, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months

[ Mon, Jan 26th 2009 ] - jason scholder

First Stem Cell Study For Spinal Injury Approved. New Hope For Back Pain Sufferers Worldwide.

[ Mon, Jan 26th 2009 ] - Market Wire

Theravance, Inc.: Theravance Submits U.S. NDA for .. for the Treatment of Hospital-Acquired Pneumonia

[ Mon, Jan 26th 2009 ] - Market Wire

HealthSpring to Webcast Its Investor Day on February 27, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

PhotoMedex Announces Results of Stockholders? Meeting

[ Mon, Jan 26th 2009 ] - Market Wire

DelSite, Inc.: DelSite, Inc. Discontinues Manufac .. DA Approval to Initiate Phase I Clinical Study fo

[ Mon, Jan 26th 2009 ] - Market Wire

Mannatech Launches Economic Stimulus Plan for Business Builders

[ Mon, Jan 26th 2009 ] - Market Wire

Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United States and Europe

[ Mon, Jan 26th 2009 ] - Market Wire

DOR BioPharma, Inc.: DOR BioPharma Announces Form .. Acute Radiation Enteritis Medical Advisory Board

[ Mon, Jan 26th 2009 ] - Market Wire

Endurance Athletes Get High-Quality Results with Low-Cal Accelerade Hydro and Endurox Restore

[ Mon, Jan 26th 2009 ] - Market Wire

St. Jude Medical Announces European CE Mark Appro .. Brain Stimulation Systems for Parkinson?s Disease

[ Mon, Jan 26th 2009 ] - Market Wire

Collaboration Between RXi Pharmaceuticals and the .. Medical School Receives a Massachusetts Life Scie

[ Mon, Jan 26th 2009 ] - Market Wire

MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer

[ Mon, Jan 26th 2009 ] - Market Wire

MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York

[ Mon, Jan 26th 2009 ] - Market Wire

Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company

[ Mon, Jan 26th 2009 ] - Market Wire

WellCare Files 2007 Annual Report on Form 10-K

[ Mon, Jan 26th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: WellPoin .. tech, Green Mountain Coffee, Peet's and Starbucks

Sun, January 25, 2009

[ Sun, Jan 25th 2009 ] - Market Wire

Crucell N.V.: Discussions on a Combination of Crucell and Wyeth Discontinued

[ Sun, Jan 25th 2009 ] - Marc Woodard

Heal Back Pain Without Surgery - Embryonic Stem Cell Update!

Fri, January 23, 2009

[ Fri, Jan 23rd 2009 ] - Market Wire

Alcon Placed for the 11th Consecutive Year on FOR .. agazine?s List of 100 Best Companies to Work For?

[ Fri, Jan 23rd 2009 ] - Market Wire

Advanced Viral Research Corp.: Advanced Viral Ann .. f Operations Due to Inability to Secure Financing

[ Fri, Jan 23rd 2009 ] - Market Wire

Urologix to Host Its Fiscal 2009 Second Quarter Conference Call

[ Fri, Jan 23rd 2009 ] - Market Wire

NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock

[ Fri, Jan 23rd 2009 ] - Market Wire

Sepracor Inc. Sets Conference Call and Webcast fo .. urth Quarter and Full-Year 2008 Operating Results

[ Fri, Jan 23rd 2009 ] - Market Wire

ImClone Systems and Bristol-Myers Squibb Update t .. ung Cancer Supplemental Biologics Application Sub

[ Fri, Jan 23rd 2009 ] - Market Wire

CLX Medical, Inc.: CLX Medical, Inc. Issues CEO C .. ith Ownership and Planned Distribution of FDA Cle

[ Fri, Jan 23rd 2009 ] - Market Wire

International Stem Cell Receives Second $1M Tranche Under $5 Million Financing

[ Fri, Jan 23rd 2009 ] - Market Wire

Alnylam Receives Clearance from FDA to Initiate P .. y with ALN-VSP for the Treatment of Liver Cancers

[ Fri, Jan 23rd 2009 ] - Market Wire

Hollis-Eden Researchers Present New Findings on M .. ancer Drug Candidate APOPTONE" (HE3235) at Americ

[ Fri, Jan 23rd 2009 ] - Market Wire

GTx Announces Conference Call to Discuss EMEA Label Changes to Fareston®

[ Fri, Jan 23rd 2009 ] - Market Wire

Centene Corporation?s Georgia Subsidiary Receives Prestigious NCQA Accreditation

[ Fri, Jan 23rd 2009 ] - Market Wire

Zacks Bull and Bear of the Day Highlights: Abbott Labs, Hubbell, Wipro, Citigroup and Infosys

Thu, January 22, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Life Technologies Sets 4th Quarter and Full Year .. ings Release Date for Thursday, February 12, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Cubist Pharmaceuticals Reports GAAP Diluted Net I .. ourth Quarter 2008 and GAAP Diluted Net Income of

[ Thu, Jan 22nd 2009 ] - Market Wire

OPKO Health Initiates Clinical Trial of the Aquashunt" to Treat Glaucoma

[ Thu, Jan 22nd 2009 ] - Market Wire

Proton Laboratories Inc.: Transparency - Sales - .. ton Laboratories Building on Years of Development

[ Thu, Jan 22nd 2009 ] - Market Wire

Bard to Host Earnings Conference Call on January 29, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

LifeVantage Names Network Marketing Expert Randal Wojta as Master Distributor for the Company

[ Thu, Jan 22nd 2009 ] - Market Wire

Simon Stevens Appointed Executive Vice President .. terprise-Wide Health Care Reform Engagement; Will

[ Thu, Jan 22nd 2009 ] - Market Wire

RXi Pharmaceuticals Appoints Rudolph Nisi, M.D. to Board of Directors

[ Thu, Jan 22nd 2009 ] - Market Wire

Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing

[ Thu, Jan 22nd 2009 ] - Market Wire

ZOLL Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators

[ Thu, Jan 22nd 2009 ] - Market Wire

Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators

[ Thu, Jan 22nd 2009 ] - Market Wire

OR-Live, Inc.: REMINDER: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration

[ Thu, Jan 22nd 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Rece .. Design Contract for Controlled Environment System

[ Thu, Jan 22nd 2009 ] - Market Wire

Tenet Announces Preliminary Results for Fourth Quarter and Full Year 2008

[ Thu, Jan 22nd 2009 ] - Market Wire

Tenet Announces Exchange Offer for up to $1.6 Bil .. egate Principal Amount of Notes Due 2011 and 2012

[ Thu, Jan 22nd 2009 ] - Market Wire

ImmunoGen, Inc. Announces Conference Call to Disc .. Second Quarter Fiscal Year 2009 Financial Results

[ Thu, Jan 22nd 2009 ] - Market Wire

BioDelivery Sciences Files Shelf Registration

Wed, January 21, 2009

[ Wed, Jan 21st 2009 ] - Market Wire

Sernova Corp.: Sernova Corp.: Resignation of Just .. dent Board of Directors Initiates Internal Review

[ Wed, Jan 21st 2009 ] - Market Wire

Iris BioTechnologies Launches Health Passport in .. ics System for Personalized and Targeted Medicine

[ Wed, Jan 21st 2009 ] - Market Wire

Reed Tuckson, M.D., Named One of Black Enterprise .. ves in Corporate America and Featured on February

[ Wed, Jan 21st 2009 ] - Market Wire

ReGen Biologics Announces Common Stock Financing .. ort Launch of Menaflex" Collagen Meniscus Implant

[ Wed, Jan 21st 2009 ] - Market Wire

Lifeline Biotechnologies, Inc. Announces Corporat .. for the Commencement of Commercialization Strate

[ Wed, Jan 21st 2009 ] - Market Wire

Abiomed to Showcase Impella® Heart Recovery Platform at STS 2009

[ Wed, Jan 21st 2009 ] - Market Wire

Nanogen Announces Changes in Merger Plans

[ Wed, Jan 21st 2009 ] - Market Wire

Abraxis BioScience Names Merck Veteran Van der Pl .. &D and Drug Development Efforts at Abraxis Health

[ Wed, Jan 21st 2009 ] - Market Wire

Myriad Pharmaceuticals, Inc.: Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat

[ Wed, Jan 21st 2009 ] - Market Wire

Celgene Corporation to Announce Fourth Quarter and Full-Year 2008 Results on January 29, 2009

[ Wed, Jan 21st 2009 ] - Market Wire

Jan Keltjens Appointed President & CEO of AngioDynamics

[ Wed, Jan 21st 2009 ] - Market Wire

Medical Action Industries 3rd Quarter Earnings Call to Take Place on February 4, 2009

[ Wed, Jan 21st 2009 ] - Market Wire

King Pharmaceuticals Reports Intent to Appeal SKELAXIN® Summary Judgment Order

[ Wed, Jan 21st 2009 ] - Market Wire

Aradigm Reports Positive Phase 2 Results with Inh .. cin Hydrochloride in Patients with Bronchiectasis

[ Wed, Jan 21st 2009 ] - Market Wire

Panacos Announces Sale of Bevirimat

[ Wed, Jan 21st 2009 ] - Market Wire

Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany

[ Wed, Jan 21st 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: AMAG Pha .. s, Logitech, Regions Financial and PetMed Express

Tue, January 20, 2009

[ Tue, Jan 20th 2009 ] - Market Wire

AspenBio Pharma, Inc.: Update: AspenBio Pharma to .. uss Preliminary Results of the AppyScore FDA Clin

[ Tue, Jan 20th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Conf .. 1, 2009 to Provide Update on Duchenne Muscular Dy

[ Tue, Jan 20th 2009 ] - Market Wire

SurModics to Webcast Annual Meeting February 2

[ Tue, Jan 20th 2009 ] - Market Wire

Opexa Provides Update on Various Corporate Developments

[ Tue, Jan 20th 2009 ] - Market Wire

Schaeffer's Street Stories: Johnson & Johnson Issues 2009 Earnings Warning

[ Tue, Jan 20th 2009 ] - Market Wire

Orthofix International Criticizes Ramius Announcement on RMG Report as Misleading and Inaccurate

[ Tue, Jan 20th 2009 ] - Market Wire

NitroMed Special Meeting of Stockholders Further .. to Consider Higher Bid From Deerfield Management

[ Tue, Jan 20th 2009 ] - Market Wire

Proton Laboratories Inc.: Proton Laboratories Dis .. Microbial Safety With Proton's Electrolyzed Water

[ Tue, Jan 20th 2009 ] - Market Wire

CORRECTING and REPLACING CytoCore and Zycom to Sign Distribution Agreement

[ Tue, Jan 20th 2009 ] - Market Wire

CLX Medical, Inc.: CLX Medical, Inc. Announces Anticipated Schedule for Reverse Stock Split

[ Tue, Jan 20th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Expands Leadershi .. dition of Daryl J. Faulkner as Executive Chairman

[ Tue, Jan 20th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma Reports Preliminary Results of AppyScore(TM) Clinical Study

[ Tue, Jan 20th 2009 ] - Market Wire

Vein Clinics of America Opens New Location in Cincinnati

[ Tue, Jan 20th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Canadian Retail Distribution Contracts

[ Tue, Jan 20th 2009 ] - Market Wire

DOR BioPharma, Inc.: DOR BioPharma Announces Enga .. f Amper, Politziner & Mattia, LLP as New Auditors

[ Tue, Jan 20th 2009 ] - Market Wire

Pioneer Behavioral Health: PHC Signs Final Agreement for Sale of Pivotal to Premier Research

[ Tue, Jan 20th 2009 ] - Market Wire

NovaBay Pharmaceuticals, Inc.: NovaBay (NBY) Appo .. D, Former Amgen President/Chief Operating Officer

Resumen: Gilead esboza las prioridades de I+D para 2009

_{//health-fitness.news-articles.net/content/2009/ .. ead-esboza-las-prioridades-de-i-d-para-2009.html}
^{Published in Health and Fitness on Wednesday, January 28th 2009 at 8:20 GMT, Last Modified on 2009-01-28 08:21:19 by Market Wire}

FOSTER CITY, California--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) ha subrayado las prioridades de desarrollo clínico de la empresa para 2009 como parte de su rueda de prensa de resultados del cuarto trimestre y de ejercicio 2008 completo. Entre las más significantes actualizaciones está la notificación de que la Agencia de Alimentos y Fármacos de EE.UU. (FDA en sus siglas en inglés) ha aprobado los programas de desarrollo de elvitegravir, GS 9350 y un régimen de combinación de dosis fija de elvitegravir, GS 9350 y Truvada® (emtricitabina y fumarato de tenofovir disoproxil), la discusión de la cronología de los anuncios clínicos de darusentan en 2009 y un mayor énfasis en esforzarse por progresar en el desarrollo de compuestos para tratar el virus de la infección de la hepatitis C (HCV en sus siglas en inglés) y enfermedad hepática.

El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única versión del texto que tendrá validez legal.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Tue, Jan 27th 2009 ] - Market Wire

Gilead Outlines R&D Priorities for 2009

[ Tue, Jan 27th 2009 ] - Market Wire

UnitedHealth Group/PacifiCare otorga ms de 5,7 mi .. para ayudar a mejorar la atencin m©dica en Calif

[ Mon, Jan 12th 2009 ] - Market Wire

Resumen: ReGen Biologics presentar el implante de .. M en la reunin de la Academia Americana de ciruja

[ Mon, Jan 12th 2009 ] - Market Wire

Resumen: Cytori crea alianza estrat©gica con GE Healthcare

[ Tue, Dec 23rd 2008 ] - Market Wire

La Comisin Europea concede la autorizacin para co .. atamiento de pacientes con sndromes mielodisplsic

[ Tue, Dec 23rd 2008 ] - Market Wire

A Comisso Europia concede ao VIDAZA autorizao com .. tratamento de pacientes com sndromes mielodispls

[ Mon, Dec 22nd 2008 ] - Market Wire

Resumen: ReGen Biologics obtiene aprobacin 510(K) .. o de andamiaje de colgeno: el implante de menisco

[ Fri, Dec 19th 2008 ] - Market Wire

Resumen: PPD ampla operaciones de investigacin por contrato en Irlanda

[ Thu, Dec 18th 2008 ] - Market Wire

Resumen: Inicio del primer programa de formacin c .. de reduccin de fracturas OsseoFix de Alphatec Spi

[ Fri, Dec 05th 2008 ] - Market Wire

Resumen: Publicados en el New England Journal of .. an la eficacia de Viread en el tratamiento de la

[ Wed, Nov 19th 2008 ] - Market Wire

El armazÃ³n de colÃ¡geno de ReGen Biologics r .. recomendacionespositivas del panel ortopÃ©dico

[ Mon, Nov 17th 2008 ] - Market Wire

Resumen: Gilead Sciences anuncia notificaciÃ³n de presentaciÃ³n ANDA para Truvada